Preliminary results of the Phase IIa trial of a folate binding protein (FBP) adjuvant cancer vaccine (E39+GM-CSF) in ovarian and endometrial cancer patients to prevent recurrence
Crossref DOI link: https://doi.org/10.1186/2051-1426-2-S3-P74
Published Online: 2014-11-06
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Greene, Julia
Schneble, Erika
Berry, John
Trappey, Alfred
Vreeland, Timothy
Clifton, Guy
McGuire, William
Maxwell, George
Ponniah, Sathibalan
Peoples, George
Article History
First Online: 6 November 2014